Petakh, P.; Kamyshna, I.; Oksenych, V.; Kainov, D.; Kamyshnyi, A.
Metformin Therapy Changes Gut Microbiota Alpha-Diversity in COVID-19 Patients with Type 2 Diabetes: The Role of SARS-CoV-2 Variants and Antibiotic Treatment. Pharmaceuticals 2023, 16, 904.
https://doi.org/10.3390/ph16060904
AMA Style
Petakh P, Kamyshna I, Oksenych V, Kainov D, Kamyshnyi A.
Metformin Therapy Changes Gut Microbiota Alpha-Diversity in COVID-19 Patients with Type 2 Diabetes: The Role of SARS-CoV-2 Variants and Antibiotic Treatment. Pharmaceuticals. 2023; 16(6):904.
https://doi.org/10.3390/ph16060904
Chicago/Turabian Style
Petakh, Pavlo, Iryna Kamyshna, Valentyn Oksenych, Denis Kainov, and Aleksandr Kamyshnyi.
2023. "Metformin Therapy Changes Gut Microbiota Alpha-Diversity in COVID-19 Patients with Type 2 Diabetes: The Role of SARS-CoV-2 Variants and Antibiotic Treatment" Pharmaceuticals 16, no. 6: 904.
https://doi.org/10.3390/ph16060904
APA Style
Petakh, P., Kamyshna, I., Oksenych, V., Kainov, D., & Kamyshnyi, A.
(2023). Metformin Therapy Changes Gut Microbiota Alpha-Diversity in COVID-19 Patients with Type 2 Diabetes: The Role of SARS-CoV-2 Variants and Antibiotic Treatment. Pharmaceuticals, 16(6), 904.
https://doi.org/10.3390/ph16060904